Pediatric cardiac arrest refractory to advanced life support: is there a role for terlipressin?

Pediatr Crit Care Med. 2010 Jan;11(1):139-41. doi: 10.1097/PCC.0b013e3181ae7834.

Abstract

Objective: Pediatric cardiac arrest unresponsive to advanced life support and several adrenaline doses has a very poor prognosis. Alternative vasopressors could improve the results of resuscitation in such cases. We report our experience with the compassionate administration of terlipressin in children who suffered in-pediatric intensive care unit cardiac arrest and did not respond to immediate advanced life support and at least three epinephrine doses.

Design: Prospective multicenter registry.

Setting: Three pediatric intensive care units at university-affiliated tertiary care children's hospitals.

Patients: Five pediatric patients, aged 5 mos to 12 yrs, with in-pediatric intensive care unit cardiac arrest unresponsive to advanced life support that included at least three epinephrine doses.

Interventions: Addition of terlipressin (10-20 microg/kg intravenous, up to two doses) to standard cardiopulmonary resuscitation.

Measurements and main results: Sustained return of spontaneous circulation was achieved in four cases, two of them were declared dead 6 and 12 hrs later, and the remaining two survived without cardiopulmonary procedures-related sequelae and with good neurologic condition.

Conclusions: Terlipressin might contribute to obtain sustained return of spontaneous circulation in children with refractory in-hospital cardiac arrest. A randomized controlled clinical trial should be conducted to investigate the optimal drug treatment in pediatric cardiac arrest.

Publication types

  • Case Reports
  • Multicenter Study

MeSH terms

  • Advanced Cardiac Life Support*
  • Child
  • Child, Preschool
  • Compassionate Use Trials
  • Dose-Response Relationship, Drug
  • Female
  • Hospitals, Pediatric
  • Humans
  • Infant
  • Intensive Care Units, Pediatric*
  • Lypressin / administration & dosage
  • Lypressin / analogs & derivatives*
  • Lypressin / pharmacology
  • Lypressin / therapeutic use
  • Male
  • Prospective Studies
  • Terlipressin
  • Treatment Outcome
  • Vasoconstrictor Agents / administration & dosage
  • Vasoconstrictor Agents / pharmacology
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Vasoconstrictor Agents
  • Lypressin
  • Terlipressin